Moreover, inhibition of mTOR signaling pathway in bladder cancer models demonstrated remarkable anti-cancer activity both in vitro and in vivo [32–34], making it an attractive target for cancer therapeutics. The gene discussed is MTOR; the disease is urinary bladder carcinoma.